In reviewing the epidemiology of recurrent abortion (RAB), we believe it is
necessary to consider the epidemiology of spontaneous abortion (SAB) as we
ll, since it is clear that even a single pregnancy loss increases the risk
for a subsequent abortion. In addition, any attempt to identify, epidemiolo
gic risk factors for SAB or RAB must deal with the fact that at least 50% o
f SABs are associated with genetic abnormalities. Given that most epidemiol
ogic studies have nor distinguished karyotypically abnormal abortuses, risk
factors are likely to be underestimated. Nevertheless, there is fair agree
ment that a variety of factors may increase risk for SAB or RAB, including
advanced maternal age, single gene mutations such as PKU or G6PD deficiency
, structural abnormalities of the uterus, poorly controlled diabetes, antip
hospholipid syndrome, and smoking. More controversial is the role of luteal
phase defect or hyperandrogenism, alloimmune factors, genital infections,
caffeine or alcohol use, and trace element or chemical exposure from ray wa
ter or in the workplace. Besides better designed epidemiologic studies to d
etect modifiable risk factors for SAB or RAB, there is a clear need for cli
nical trials of therapy for RAB which meet minimum epidemiologic standards
including randomization, double-blinded (when possible), and placebo-contro
lled (when ethical).